Direct assessment of muscle glycogen storage after mixed meals in normal and type 2 diabetic subjects

American Journal of Physiology - Endocrinology and Metabolism

Volumn 284, Issue 4 47-4, 2003, Pages

  Carey, P E ^a   Halliday, J ^b   Snaar, J E M ^b   Morris, P G ^b   Taylor, R ^a,c  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Insulin resistance; Magnetic resonance spectroscopy; Type 2 diabetes

Indexed keywords

GLUCOSE; GLYCOGEN; INSULIN;

ADULT; ARTICLE; BODY MASS; CALORIC INTAKE; CARBOHYDRATE INTAKE; CARBON NUCLEAR MAGNETIC RESONANCE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FAT INTAKE; FEMALE; GASTROCNEMIUS MUSCLE; GLYCOGEN MUSCLE LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; MUSCLE METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTEIN INTAKE;

EID: 0037376947     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00471.2002     Document Type: Article

References (43)

1. Abriara C, Buchanan B, and Hodges L. Modification of the glycogen deposition by priming glucose loads: the second meal phenomenon. Am J Clin Nutr 45: 952-957, 1987.
2. Akinmokun A, Selby PL, Ramaiya K, and Alberti KGMM. The short insulin tolerance test for determination of insulin sensitivity: a comparison with the euglycaemic clamp. Diabet Med 9: 432-437, 1992.
3. Bachmann OP, Dahl DB, Brechtel K, Manchann J, Haap M, Maier T, Loviscach M, Stumvoll M, Claussen CD, Schick F, Haring HU, and Jacob S. Effects of intravenous and dietary lipid challange on intramyocellular lipid content and the relation with insulin sensitivity in humans. Diabetes 50: 2579-2584, 2001.
4. Basu A, Basu R, Shah P, Vella A, Johnson CM, Jensen M, Nair KS, Schwenk WF, and Rizza RA. Type 2 diabetes impairs splanchnic uptake of glucose but does not alter intestinal glucose absorption during enteral feeding: additional evidence for a defect in hepatic glucokinase activity. Diabetes 50: 1351-1362, 2001.
5. Boden G, Leped B, Schatz M, Homko C, and Lemieux S. Effects of acute changes in plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects. Diabetes 50: 1612-1617, 2001.
6. Bogardus C, Lillioja S, Stone K, and Mott D. Correlation between muscle glycogen synthase activity and in vivo insulin action in man. J Clin Invest 73: 1185-1190, 1984.
7. Capaldo B, Gastaldelli A, Antoniello S, Auletta M, Pardo F, Ciociaro D, Guida R, Ferrannini E, and Sacca L. Splanchnic and leg substrate exchange after ingestion of a natural mixed meal in humans. Diabetes 48: 958-966, 1999.
8. Cline GW, Petersen KF, Krssak M, Shen J, Hundal RS, Trajanoski Z, Inzucchi S, Dresner A, Rothman DL, and Shulman GI. Decreased glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes. N Eng J Med 341: 240-246, 1999.
9. DECODE Study Group. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. Lancet 354: 617-621, 1999.
10. Ferreira LD, Pulawa LK, Jensen DR, and Eckel RH. Overexpressing human lipoprotein lipase in mouse skeletal muscle is associated with insulin resistance. Diabetes 50: 1064-1068, 2001.
11. Firth RG, Bell PM, Marsh HM, Hansen I, and Rizza RA. Postprandial hyperglycaemia in patients with non-insulin dependent diabetes mellitus. J Clin Invest 77: 1525-1232, 1986.
12. Hanefeld M, Fischer S, Julius U, Schulze J, Schwanebeck U, Schwanebeck H, Ziegelasch HJ, and Lindner J. Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up. Diabetologia 39: 1577-1583, 1996.
13. Heymsfield S, McManus C, Stevens V, and Smith J. Muscle mass: reliable indicator of protein-energy malnutrition severity and outcome. Am J Clin Nutr 35: 1192-1199, 1982.
14. Hundal RS, Krssak M, Dufour S, Laurent D, LeBon V, Chandramouli V, Inzucchi SE, Schumann WC, Petersen KF, Landau BR, and Shulman GI. Mechanism by which metformin reduces glucose production in type 2 diabetes. Diabetes 49: 2063-2069, 2000.
15. Jackson KG, Robertson MD, Fielding BA, Frayn KN, and Williams CM. Second meal effect: modified sham feeding does not provoke the release of stored triacylglycerol from a previous high-fat meal. Br J Nutr 85: 149-156, 2001.
16. Jackson RA, Hamling JB, Sim BM, Hawa MI, Blix PM, and Nabarro JDN. Peripheral lactate and oxygen metabolism in man: the influence of oral glucose loading. Metabolism 36: 144-150, 1987.
17. Johnson AB, Argyraki M, Thow JC, Jones IR, Broughton DL, Miller M, and Taylor R. The effect of sulphonylurea therapy on skeletal muscle glycogen synthase activity and insulin secretion in newly presenting (non-insulin-dependent) diabetic patients. Diabet Med 8: 243-253, 1991.
18. Johnson AB, Webster JM, Sum CF, Heseltine L, Argyraki M, Cooper BG, and Taylor R. The impact of metformin therapyon hepatic glucose production and skeletal muscle glycogen synthase activity in overweight type II diabetic patients. Metabolism 42: 1217-1222, 1993.
19. Kelley D, Mitrakou A, Schwenk F, Benn J, Sonnenberg G, Arcangell M, Aoki T, Sorensen J, Berger M, Sonksen P, and Gerich J. Skeletal muscle glycolysis, oxidation, and storage of an oral glucose load. J Clin Invest 81: 1563,1571, 1988.
20. Kelley D, Mokan M, and Veneman T. Impaired postprandial glucose utilization in non-insulin dependent diabetes mellitus. Metabolism 43: 1549-1557, 1994.
21. Kelley DE and Mandarino LJ. Hyperglycemia normalizes insulin-stimulated skeletal muscle glucose oxidation and storage in noninsulin-dependent diabetes mellitus. J Clin Invest 86: 1999-2007, 1990.
22. Levin K, Daa Schroder H, Alford FP, and Beck-Nielsen H. Morphometric documentation of abnormal intramyocellular fat storage and reduced glycogen in obese patients with Type II diabetes. Diabetologia 44: 824-833, 2001.
23. Magnusson I, Rothman DL, Katz LD, Shulman RG, and Shulman GI. Increased rate of gluconeogenesis in type-II diabetes-mellitus - a C-13 nuclear-magnetic-resonance study. J Clin Invest 90: 1323-1327, 1992.
24. Miles JM, Walewicz D, Park Y, Russell-Lopez C, Windsor S, Isley WL, and Harris WS. Systemic and forearm triglyceride metabolism: fate of lipoprotein lipase-generated glycerol and free fatty acids (Abstract). Diabetologia 45, Suppl 2: A53, 2002.
25. Mitrakou A, Kelley D, Veneman T, Jenssen T, Pangburn T, Reilly J, and Gerich J. Contribution of abnormal muscle and liver glucose metabolism to postprandial hyperglycemia in NIDDM. Diabetes 39: 1381-1390, 1990.
26. National Radiological Protection Board. Principles for the protection of patients and volunteers during clinical magnetic resonance procedures. Documents of the NRPB 2: 19, 1991.
27. Nielsen MF, Basu R, Wise S, Caumo A, Cobelli C, and Rizza RA. Normal glucose-induced suppression of glucose production but impaired stimulation of glucose disposal in type 2 diabetes. Diabetes 47: 1735-1747, 1998.
28. Perseghin G, Scifo P, De CF, Pagliato E, Battezzati A, Arcelloni C, Vanzulli A, Testolin G, Pozza G, Del Maschio A, and Luzi L. Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes 48: 1600-1606, 1999.
29. Radziuk J and Inculet R. The effects of ingested and intravenous glucose and glucogenic substrate in normal man. Diabetes 32: 977-981, 1983.
30. Reich A, Abraira C, Bruken R, and Soneru I. Potentiation of glucose-stimulated insulin release by tolazamide and paradoxical absence of glucose facilitation (Staub effect) in non-insulin dependent diabetes. Metabolism 35: 367-370, 1986.
31. Shaka AJ, Keeler J, and Freeman R. Evaluation of a new broadband decoupling sequence: WALTZ-16. J Magn Res 53: 313-340, 1983.
32. 13C nuclear magnetic resonance spectroscopy. N Eng J Med 322: 223-228, 1990.
33. Singhal P, Caumo A, Carey PE, Cobelli C, and Taylor R. Regulation of endogenous glucose production after a mixed meal in type 2 diabetes. Am J Physiol Endocrinol Metab 283: E275-E283, 2002.
34. Staub H. Untersuchungen uber den Zuckerstoffwechsel des Munchen. Z Klin Med 91: 44-48, 1921.
35. Taylor R, Magnussen I, Rothman DL, Cline GW, Caumo A, Cobelli C, and Shulman GI. Direct assessment of liver glycogen storage by 13C-nuclear magnetic resonance spectroscopy and regulation of glucose homeostasis after a mixed meal in normal subjects. J Clin Invest 97: 126-132, 1996.
36. Taylor R, Price TB, Katz LD, Shulman RG, and Shulman GI. Direct measurement of change in muscle glycogen Concentration after a mixed meal in normal subjects. Am J Physiol Endocrinol Metab 265: E224-E229, 1993:
37. Taylor R, Price TB, Rothman DR, Shulman RG, and Shulman GI. Validation of 13C-NMR measurement of human muscle glycogen by comparison with biopsy and direct biochemical measurement. Mag Res Med 27: 13-20, 1992.
38. Traugott K. Uber das Verhalten des Blutzucker Spiegels bei Wiederholter unf verschiedener Art enteraler Zuckerzufuhr und dessen Bedeutung fur die Leberfunktion. Klin Wocheschr 1: 892-894, 1922.
39. Turk D, Alzaid A, Dinneen S, Nair KS, and Rizza R. The effects of non-insulin-dependent diabetes mellitus on the kinetics of onset of insulin action in hepatic and extrahepatic tissues. J Clin Invest 95: 755-762, 1995.
40. Van der Boogaart A. MRUI Manual V 96.3. A User's Guide to the Magnetic Resonance User Interface Software Package. Delft, The Netherlands: Delft Technical University Press, 1997.
41. Wolever TMS, Jenkins DJA, Ocana AM, Rao VA, and Collier GR. Second-meal effect: low glycaemic index foods eaten at dinner improve subsequent breakfast glycaemic response. Am J Clin Nutr 48: 1041-1047, 1988.
42. Wright KS, Beck-Nielsen H, Kolterman OG, and Mandarino LJ. Decreased activation of skeletal muscle glycogen synthase by mixed meal ingestion in NIDDM. Diabetes 37: 436-440, 1988.
43. Young AA, Bogardus C, Wolfe-Lopez D, and Mott DM. Muscle glycogen synthesis and disposition of infused glucose in humans with reduced rates of insulin-mediated carbohydrate storage. Diabetes 37: 303-308, 1988.